China Resourcesnjiu Medical & Pharmaceutical Co (SZSE:000999) Ending Cash Position : ¥6,724 Mil (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is China Resourcesnjiu Medical & Pharmaceutical Co Ending Cash Position?

China Resourcesnjiu Medical & Pharmaceutical Co's Ending Cash Position for the quarter that ended in Mar. 2024 was ¥6,724 Mil.

China Resourcesnjiu Medical & Pharmaceutical Co's quarterly Ending Cash Position increased from Sep. 2023 (¥6,126 Mil) to Dec. 2023 (¥6,215 Mil) and increased from Dec. 2023 (¥6,215 Mil) to Mar. 2024 (¥6,724 Mil).

China Resourcesnjiu Medical & Pharmaceutical Co's annual Ending Cash Position declined from Dec. 2021 (¥2,403 Mil) to Dec. 2022 (¥2,361 Mil) but then increased from Dec. 2022 (¥2,361 Mil) to Dec. 2023 (¥6,215 Mil).

China Resourcesnjiu Medical & Pharmaceutical Co Ending Cash Position Historical Data

The historical data trend for China Resourcesnjiu Medical & Pharmaceutical Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Resourcesnjiu Medical & Pharmaceutical Co Ending Cash Position Chart

China Resourcesnjiu Medical & Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

2,887.74

2,978.65

2,403.36

2,361.43

6,215.10

China Resourcesnjiu Medical & Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															4,436.06	5,994.20	6,125.63	6,215.10	6,724.07

China Resourcesnjiu Medical & Pharmaceutical Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

China Resourcesnjiu Medical & Pharmaceutical Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	2361.427	+	3853.677
	=	6,215

China Resourcesnjiu Medical & Pharmaceutical Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	6215.104	+	508.968
	=	6,724

China Resourcesnjiu Medical & Pharmaceutical Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of China Resourcesnjiu Medical & Pharmaceutical Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

China Resourcesnjiu Medical & Pharmaceutical Co (SZSE:000999) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Resources Sanjiu Medical & Pharmaceutical Co Ltd (SZSE:000999) » Definitions » Ending Cash Position

Traded in Other Exchanges

N/A

Address

High-Tech Park, Lake Street Mission Hills, Longhua District, Shenzhen, CHN, 518110

Website

http://www.999.com.cn

China Resources Sanjiu Medical & Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is engaged in the research and development, production and sale of pharmaceutical products, healthcare products, and medical appliances under the brand name 999, which includes OTC, antibiotic and raw material drug. The other brands under which the company offers its products are Lee King, Shunfeng, and Tianhe. The company's core business is located in OTC and Chinese medicine prescription drugs, OTC core products in the cold, gastrointestinal, skin, pediatric, cough and orthopedic drugs occupy a higher market share; prescription drug products in traditional Chinese medicine formula granules, cardiovascular and cerebrovascular, anti-tumor in the field of anti-infection and other areas.

China Resourcesnjiu Medical & Pharmaceutical Co (SZSE:000999) Headlines

No Headlines